{"id":226,"date":"2010-03-31T14:25:35","date_gmt":"2010-03-31T05:25:35","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/2010\/03\/31\/2007\/"},"modified":"2017-09-06T11:48:32","modified_gmt":"2017-09-06T02:48:32","slug":"2007","status":"publish","type":"post","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/achievement\/20100331226\/","title":{"rendered":"2007\u5e74\uff08\u5e73\u621019\u5e74\u5ea6\uff09\u306e\u7814\u7a76\u696d\u7e3e"},"content":{"rendered":"

A. \u8ad6\u6587<\/h3>\n

\u3010\u8457\u66f8\u3011<\/h4>\n
    \n
  1. Matsuda Z, Iga M, Miyauchi K, Komano J, Morishita K, Okayama A, Tsubouchi H. Section 7 In vitro translation to study HIV protease activity. In: In Vitro Transcription and Translation Protocols Second Edition \/ Methods in Molecular Biology 375, ed. Guido Grandi, pp.135-149(2007). Humana Press, New York. (May)<\/li>\n
  2. \u5ca1\u5c71\u662d\u5f66. \u7b2c\u2161\u90e8\u3000\u4e00\u822c\u7684\u306a\u691c\u67fb\u3000\u7b2c15\u7ae0\u3000\u767d\u8840\u7403\u50cf, \u7b2c16\u7ae0\u3000\u305d\u306e\u4ed6.\u3000\u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u81e8\u5e8a\u691c\u67fb\u5024, \u793e\u56e3\u6cd5\u4eba\u65e5\u672c\u85ac\u5b66\u4f1a, 42-45(2007).\u3000\u682a\u5f0f\u4f1a\u793e\u6771\u4eac\u5316\u5b66\u540c\u4eba, \u6771\u4eac. (12\u670812\u65e5)<\/li>\n<\/ol>\n

    \u3010\u539f\u8457\u3011<\/h4>\n
      \n
    1. Takajo I, Umeki K, Morishita K, Yamamoto I, Kubuki Y, Hatakeyama K, Kataoka H, Okayama A. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus Type 1 carriers in NOD\/SCID\/gammac(null) (NOG) mice. Int J Cancer. 2007;121:2205-2211. (November)<\/li>\n
    2. \u6885\u6728\u4e00\u7f8e, \u7dd2\u65b9\u967d\u4e00, \u5cf6\u7530\u96c5\u5df3, \u91ce\u6751\u5275, \u9ad9\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u5927\u5b66\u75c5\u9662\u691c\u67fb\u90e8\u306b\u304a\u3051\u308b\u6280\u5e2b\u30fb\u5b66\u751f\u6559\u80b2. \u5bae\u5d0e\u770c\u81e8\u5e8a\u885b\u751f\u691c\u67fb\u6280\u5e2b\u4f1a\u8a8c. 2008;88:38-40. (1\u6708)<\/li>\n<\/ol>\n

      \u3010\u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09\u3011<\/h4>\n
        \n
      1. \u4e2d\u6751\u61b2\u4e00, \u9577\u53cb\u5b89\u5f18, \u7530\u4e2d\u5f26\u4e00, \u843d\u5408\u4fca\u96c4.\u3000\u672b\u68a2\u8840\u306b\u7570\u5e38\u7d30\u80de\u3092\u8a8d\u3081\u305a\u3001\u30cb\u30e5\u30fc\u30e2\u30b7\u30b9\u30c1\u30b9\u80ba\u708e\u3092\u5951\u6a5f\u306bATL\u304f\u3059\u3076\u308a\u578b\u3068\u8a3a\u65ad\u3057\u305f1\u4f8b.\u3000\u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c. 2007;72:12-16. (10\u6708)<\/li>\n
      2. \u9ed2\u6728\u660c\u5e78, \u6885\u5317\u90a6\u5f66, \u5c71\u5143\u7f8e\u4fdd\u5b50, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u7532\u6590\u6cf0\u6587, \u7530\u4e2d\u5f26\u4e00, \u4f50\u3005\u6728\u9686, \u5ca1\u5c71\u662d\u5f66. \u5168\u8eab\u6027\u30a8\u30ea\u30c6\u30de\u30c8\u30fc\u30c7\u30b9\u5408\u4f75\u598a\u5a20\u30fb\u51fa\u7523\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u4e5d\u5dde\u30ea\u30a6\u30de\u30c1. 2008;28:1,23-27. (3\u6708)<\/li>\n
      3. \u9577\u53cb\u5b89\u5f18, \u7530\u4e2d\u5f26\u4e00, \u4e2d\u6751\u61b2\u4e00, \u843d\u5408\u4fca\u96c5, \u897f\u7530\u5353\u723e, \u7530\u4ee3\u5b8f\u4e00, \u7af9\u4e2d\u6643\u53f8, \u5927\u5712\u535a\u6587, \u77f3\u4e95\u9686\u96c4.\u3000\u5f53\u9662\u306b\u304a\u3051\u308b\u80ba\u30a2\u30b9\u30da\u30eb\u30ae\u30eb\u30b9\u75c7\u306e\u81e8\u5e8a\u7684\u691c\u8a0e.\u3000\u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u533b\u5b66\u4f1a\u8a8c. 2008;31:80-85. (3\u6708)<\/li>\n<\/ol>\n

        \u3010\u7dcf\u8aac\u3011<\/h4>\n

        –<\/p>\n

        \"btn-pagetop1\"<\/a><\/div>\n

        B. \u767a\u8868<\/h3>\n

        \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/h4>\n
          \n
        1. \u5c0f\u6a4b\u5409\u535a, \u5927\u690d\u7965\u5f18, \u4e0a\u91ce\u53f2\u6717, \u5c0f\u53f8\u4e45\u5fd7, \u77e2\u6728\u771f\u4e00, \u6bdb\u5229\u572d\u4e8c, \u5c3e\u9577\u8c37\u9756, \u798f\u7530\u5b9f, \u5409\u7530\u8015\u4e00\u90ce, \u5bae\u4e0b\u4fee\u884c, \u5ca1\u4e09\u559c\u7537. \u7d50\u6838\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u5f53\u9662\u3067\u306eQuantiFERON(QFT-TB)\u306e\u691c\u67fb\u6210\u7e3e, \u7b2c81\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a. 2007. (4\u670810\u65e5-11\u65e5(10\u65e5\u767a\u8868), \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02\u3001\u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928)<\/li>\n
        2. \u5c0f\u6a4b\u5409\u535a, \u5927\u690d\u7965\u5f18, \u4e0a\u91ce\u53f2\u6717, \u5c0f\u53f8\u4e45\u5fd7, \u77e2\u6728\u771f\u4e00, \u6bdb\u5229\u572d\u4e8c, \u5c3e\u9577\u8c37\u9756, \u798f\u7530\u5b9f, \u5409\u7530\u8015\u4e00\u90ce, \u5bae\u4e0b\u4fee\u884c, \u5ca1\u4e09\u559c\u7537. \u6d3b\u52d5\u6027\u7d50\u6838\u304a\u3088\u3073\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u306b\u5bfe\u3059\u308bQuantiFERON TB-2G\u3068T-SPOT.TB\u306e\u6210\u7e3e\u306e\u6bd4\u8f03. \u7b2c81\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a. 2007. (4\u670810\u65e5-11\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02\u3001\u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928)<\/li>\n
        3. \u5927\u690d\u7965\u5f18, \u5c3e\u9577\u8c37\u9756, \u5bae\u4e0b\u4fee\u884c, \u5c0f\u53f8\u4e45\u5fd7, \u4e0a\u91ce\u53f2\u6717, \u6bdb\u5229\u572d\u4e8c, \u77e2\u6728\u771f\u4e00, \u798f\u7530\u5b9f, \u5409\u7530\u8015\u4e00\u90ce, \u5c0f\u6a4b\u5409\u535a, \u5ca1\u4e09\u559c\u7537. Acute Hypoxemic Respiratory Failure(AHRF)\u3092\u304d\u305f\u3057\u305f\u5e02\u4e2d\u80ba\u708e\u306e\u89e3\u6790. \u7b2c81\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a. 2007. (4\u670810\u65e5-11\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02\u3001\u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928)<\/li>\n
        4. \u6bdb\u5229\u572d\u4e8c, \u5bae\u4e0b\u4fee\u884c, \u5927\u690d\u7965\u5f18, \u5c0f\u53f8\u4e45\u5fd7, \u4e0a\u91ce\u53f2\u6717, \u77e2\u6728\u771f\u4e00, \u798f\u7530\u5b9f, \u5c3e\u9577\u8c37\u9756, \u5409\u7530\u8015\u4e00\u90ce, \u5c0f\u6a4b\u5409\u535a, \u5ca1\u4e09\u559c\u7537. \u611f\u67d3\u6027\u80ba\u75be\u60a3\u306b\u304a\u3051\u308b\u6c17\u7ba1\u652f\u5185\u8996\u93e1\u306e\u6709\u7528\u6027. \u7b2c81\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a. 2007. (4\u670810\u65e5-11\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02\u3001\u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928)<\/li>\n
        5. \u77e2\u6728\u771f\u4e00, \u5bae\u4e0b\u4fee\u884c, \u5927\u690d\u7965\u5f18, \u5c0f\u53f8\u4e45\u5fd7, \u4e0a\u91ce\u53f2\u6717, \u6bdb\u5229\u572d\u4e8c, \u5c3e\u9577\u8c37\u9756, \u798f\u7530\u5b9f, \u5409\u7530\u8015\u4e00\u90ce, \u5c0f\u6a4b\u5409\u535a, \u5ca1\u4e09\u559c\u7537. \u4e0b\u6c17\u9053\u691c\u4f53\u304b\u3089\u771f\u83cc\u3092\u6c17\u7ba1\u652f\u5185\u8996\u93e1\u3067\u5206\u96e2\u3057\u5f97\u305f\u75c7\u4f8b\u306e\u89e3\u6790. \u7b2c81\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a. 2007. (4\u670810\u65e5-11\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02\u3001\u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928)<\/li>\n
        6. \u9ed2\u6728\u660c\u5e78, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u7532\u6590\u6cf0\u6587, \u4f50\u3005\u6728\u9686, \u5ca1\u5c71\u662d\u5f66, \u6cb3\u91ce\u559c\u7f8e\u5b50, \u5e38\u5f6c, \u548c\u7530\u662d\u4ec1. Streptococcus suis \u304a\u3088\u3073 Pasturella multocida \u611f\u67d3\u306b\u3088\u308b\u96fb\u6483\u578b\u7d2b\u6591\u75c5\u306e1\u4f8b.\u3000\u7b2c81\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a.\u30002007. (4\u670810\u65e5-11\u65e5, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02\u3001\u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928)<\/li>\n
        7. \u9ad8\u57ce\u4e00\u90ce, \u6885\u5317\u90a6\u5f66, \u7532\u6590\u6cf0\u6587, \u9ed2\u6728\u660c\u5e78, \u4f50\u3005\u6728\u9686, \u5ca1\u5c71\u662d\u5f66. NOG\u30de\u30a6\u30b9\u306b\u304a\u3051\u308bHTLV-1\u611f\u67d3\u7d30\u80de\u52d5\u614b\u306e\u691c\u8a0e. \u7b2c81\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a.\u30002007. (4\u670810\u65e5-11\u65e5, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02\u3001\u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928)<\/li>\n
        8. \u6885\u5317\u90a6\u5f66, \u65e5\u9ad8\u5229\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u7532\u6590\u6cf0\u6587, \u9ed2\u6728\u660c\u5e78, \u4f50\u3005\u6728\u9686, \u5ca1\u5c71\u662d\u5f66. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u304a\u3051\u308b\u65b0\u898f\u60c5\u5831\u4f1d\u9054\u7269\u8cea\u30de\u30a4\u30af\u30ed\u30d1\u30fc\u30c6\u30a3\u30af\u30eb\u306e\u89e3\u6790.\u3000\u7b2c51\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\uff0f\u7b2c16\u56de\u56fd\u969b\u30ea\u30a6\u30de\u30c1\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0.\u30002007. (4\u670826\u65e5-29\u65e5, \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02\u3001\u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c)<\/li>\n
        9. \u9ed2\u6728\u660c\u5e78, \u6885\u5317\u90a6\u5f66, \u5c71\u5143\u7f8e\u4fdd\u5b50, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u7532\u6590\u6cf0\u6587, \u4f50\u3005\u6728\u9686, \u5ca1\u5c71\u662d\u5f66. \u5f53\u79d1\u306b\u304a\u3051\u308b\u30b9\u30c6\u30ed\u30a4\u30c9\u6027\u9aa8\u7c97\u9b06\u75c7\u306e\u6cbb\u7642\u5b9f\u614b.\u3000\u7b2c51\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\uff0f\u7b2c16\u56de\u56fd\u969b\u30ea\u30a6\u30de\u30c1\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0.\u30002007. (4\u670826\u65e5-29\u65e5, \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02\u3001\u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c)<\/li>\n
        10. \u5c0f\u6a4b\u5409\u535a, \u5927\u690d\u7965\u5f18, \u4e0a\u91ce\u53f2\u6717, \u5c0f\u53f8\u4e45\u5fd7, \u77e2\u6728\u771f\u4e00, \u6bdb\u5229\u572d\u4e8c, \u5c3e\u9577\u8c37\u9756, \u798f\u7530\u5b9f, \u5409\u7530\u8015\u4e00\u90ce, \u5bae\u4e0b\u4fee\u884c, \u5ca1\u4e09\u559c\u7537. \u6d3b\u52d5\u6027\u7d50\u6838\u3068\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u306b\u5bfe\u3059\u308bQuantiFERON TB-2G\u306e\u81e8\u5e8a\u8a55\u4fa1. \u7b2c47\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2007. (5\u670810\u65e5-12\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a\u3001\u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        11. \u5c0f\u6a4b\u5409\u535a, \u5927\u690d\u7965\u5f18, \u4e0a\u91ce\u53f2\u6717, \u5c0f\u53f8\u4e45\u5fd7, \u77e2\u6728\u771f\u4e00, \u6bdb\u5229\u572d\u4e8c, \u5c3e\u9577\u8c37\u9756, \u798f\u7530\u5b9f, \u5409\u7530\u8015\u4e00\u90ce, \u5bae\u4e0b\u4fee\u884c, \u677e\u5cf6\u654f\u6625, \u5ca1\u4e09\u559c\u7537. \u6700\u8fd1\u306b\u304a\u3051\u308b\u4e0b\u80ba\u91ce\u7d50\u6838\u306e\u52d5\u5411, \u7b2c47\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2007. (5\u670810\u65e5-12\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a\u3001\u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        12. \u5bae\u4e0b\u4fee\u884c, \u5c0f\u53f8\u4e45\u5fd7, \u5927\u690d\u7965\u5f18, \u4e0a\u91ce\u53f2\u6717, \u6bdb\u5229\u572d\u4e8c, \u77e2\u6728\u771f\u4e00, \u5c3e\u9577\u8c37\u9756, \u798f\u7530\u5b9f, \u5409\u7530\u8015\u4e00\u90ce, \u5c0f\u6a4b\u5409\u535a, \u5ca1\u4e09\u559c\u7537. \u80ba\u708e\u30af\u30e9\u30df\u30b8\u30a2IgM\u6297\u4f53\u691c\u51fa\u7528\u8840\u6e05\u8a3a\u65ad\u6cd5\u306e\u8a55\u4fa1\uff13\uff0d\u591a\u65bd\u8a2d\u5171\u540c\u81e8\u5e8a\u7814\u7a76. \u7b2c47\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2007. (5\u670810\u65e5-12\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a\u3001\u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        13. \u5bae\u4e0b\u4fee\u884c, \u5c0f\u53f8\u4e45\u5fd7, \u5927\u690d\u7965\u5f18, \u4e0a\u91ce\u53f2\u6717, \u6bdb\u5229\u572d\u4e8c, \u77e2\u6728\u771f\u4e00, \u5c3e\u9577\u8c37\u9756, \u798f\u7530\u5b9f, \u5409\u7530\u8015\u4e00\u90ce, \u5c0f\u6a4b\u5409\u535a, \u5ca1\u4e09\u559c\u7537. \u80ba\u708e\u30af\u30e9\u30df\u30b8\u30a2IgM\u6297\u4f53\u691c\u51fa\u7528\u8840\u6e05\u8a3a\u65ad\u6cd5\u306e\u8a55\u4fa11-\u30d2\u30bf\u30b6\u30a4\u30e0\u6cd5\u306e\u554f\u984c\u70b9. \u7b2c47\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2007. (5\u670810\u65e5-12\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a\u3001\u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        14. \u5bae\u4e0b\u4fee\u884c, \u5c0f\u53f8\u4e45\u5fd7, \u5927\u690d\u7965\u5f18, \u4e0a\u91ce\u53f2\u6717, \u6bdb\u5229\u572d\u4e8c, \u77e2\u6728\u771f\u4e00, \u5c3e\u9577\u8c37\u9756, \u798f\u7530\u5b9f, \u5409\u7530\u8015\u4e00\u90ce, \u5c0f\u6a4b\u5409\u535a, \u5ca1\u4e09\u559c\u7537. \u80ba\u708e\u30af\u30e9\u30df\u30b8\u30a2IgM\u6297\u4f53\u691c\u51fa\u7528\u8840\u6e05\u8a3a\u65ad\u6cd5\u306e\u8a55\u4fa12-\u57fa\u790e\u7684\u691c\u8a0e. \u7b2c47\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2007. (5\u670810\u65e5-12\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a\u3001\u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        15. \u4e0a\u91ce\u53f2\u6717, \u5c3e\u9577\u8c37\u9756, \u5927\u690d\u7965\u5f18, \u5c0f\u53f8\u4e45\u5fd7, \u77e2\u6728\u771f\u4e00, \u6bdb\u5229\u572d\u4e8c, \u798f\u7530\u5b9f, \u5c0f\u6a4b\u5409\u535a, \u5409\u7530\u8015\u4e00\u90ce, \u5bae\u4e0b\u4fee\u884c, \u5ca1\u4e09\u559c\u7537. BAL\u3067\u597d\u9178\u7403\u5897\u52a0\u3092\u8a8d\u3081\u305f\u75c7\u4f8b\u306e\u89e3\u6790. \u7b2c47\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2007. (5\u670810\u65e5-12\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a\u3001\u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        16. \u6bdb\u5229\u572d\u4e8c, \u5927\u690d\u7965\u5f18, \u5c0f\u53f8\u4e45\u5fd7, \u4e0a\u91ce\u53f2\u6717, \u77e2\u6728\u771f\u4e00, \u5c3e\u9577\u8c37\u9756, \u798f\u7530\u5b9f, \u5c0f\u6a4b\u5409\u535a, \u5409\u7530\u8015\u4e00\u90ce, \u5bae\u4e0b\u4fee\u884c, \u5ca1\u4e09\u559c\u7537. \u547c\u5438\u5668\u611f\u67d3\u75c7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u6c17\u7ba1\u652f\u5185\u8996\u93e1\u691c\u67fb\u306e\u6709\u7528\u6027\u3068\u554f\u984c\u70b9. \u7b2c47\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2007. (5\u670810\u65e5-12\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a\u3001\u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        17. \u77e2\u6728\u771f\u4e00, \u5927\u690d\u7965\u5f18, \u6bdb\u5229\u572d\u4e8c, \u4e0a\u91ce\u53f2\u6717, \u5c3e\u9577\u8c37\u9756, \u798f\u7530\u5b9f, \u5bae\u4e0b\u4fee\u884c, \u5c0f\u6a4b\u5409\u535a, \u5ca1\u4e09\u559c\u7537. \u30d4\u30a8\u30be\u7d20\u5b50\u578b\u96fb\u5b50\u8074\u8a3a\u5668\u306b\u3088\u308b\u80ba\u97f3\u306e\u89e3\u6790-\u7b2c2\u5831-. \u7b2c47\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2007. (5\u670810\u65e5-12\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a\u3001\u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        18. \u77e2\u6728\u771f\u4e00, \u5927\u690d\u7965\u5f18, \u6bdb\u5229\u572d\u4e8c, \u4e0a\u91ce\u53f2\u6717, \u5c3e\u9577\u8c37\u9756, \u798f\u7530\u5b9f, \u5bae\u4e0b\u4fee\u884c, \u5c0f\u6a4b\u5409\u535a, \u5ca1\u4e09\u559c\u7537. \u6975\u7d30\u5f84\u6c17\u7ba1\u652f\u93e1\u306e\u7d50\u7bc0\u5f71\u3092\u5448\u3059\u308b\u547c\u5438\u5668\u611f\u67d3\u75c7\u3078\u306e\u5fdc\u7528. \u7b2c47\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2007. (5\u670810\u65e5-12\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a\u3001\u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        19. \u5927\u690d\u7965\u5f18, \u5c3e\u9577\u8c37\u9756, \u5bae\u4e0b\u4fee\u884c, \u5c0f\u53f8\u4e45\u5fd7, \u4e0a\u91ce\u53f2\u6717, \u6bdb\u5229\u572d\u4e8c, \u77e2\u6728\u771f\u4e00, \u798f\u7530\u5b9f, \u5409\u7530\u8015\u4e00\u90ce, \u5c0f\u6a4b\u5409\u535a, \u5ca1\u4e09\u559c\u7537. \u8ee2\u5e30\u304b\u3089\u307f\u305fALI\/ARDS\u3092\u304d\u305f\u3057\u305f\u5e02\u4e2d\u80ba\u708e\u306e\u89e3\u6790. \u7b2c47\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2007. (5\u670810\u65e5-12\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a\u3001\u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        20. \u4e45\u5fb3\u5f13\u5b50, \u9038\u898b\u7965\u53f8, \u6751\u4e0a\u9f8d\u6587, \u7802\u7530\u82b3\u79c0, \u4e0a\u91ce\u53f2\u6717, \u798f\u7530\u5b9f, \u4e45\u4fdd\u967d\u53f8. \u591a\u5f69\u306a\u508d\u816b\u760d\u6027\u795e\u7d4c\u75c7\u5019\u7fa4\u3092\u5448\u3057\u305f\u80ba\u5c0f\u7d30\u80de\u764c\u306e1\u4f8b. \u7b2c96\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e2d\u56fd\u5730\u65b9\u4f1a.\u30002007. (5\u670819\u65e5, \u5ca1\u5c71\u770c\u5ca1\u5c71\u5e02, \u5ca1\u5c71\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        21. Ishida Y, Yamashita K, Sasaki H, Takajou I, Kubuki Y, Morishita K, Tsubouchi H, Okayama A. Search for ATL markers by SerumProteomic Analysis; Association of ATL with Complement System. 13th International conference on human retrovirology: HTLV and related viruses. 2007. (May 21-25, Japan Kanagawa-ken, Hakone Prince Hotel).<\/li>\n
        22. Yamaguchi K, Uozumi K, Taguchi H, Kikuchi H, Okayama A, Kamihira S, Hino S, Nosaka K, Watanabe T. Nationwide Cohort Study of HTLV-1 Carriers in Japan: Joint Study on Predisposing Factors of ATL Development (JSPFAD). 13th International conference on human retrovirology: HTLV and related viruses. 2007. (May 21-25, Japan Kanagawa-ken, Hakone Prince Hotel).<\/li>\n
        23. Ishida Y, Sakakibara Y, Yamasaki M, Morinaga H, Akamatsu E, Yukizaki C, Sakai M, Torii E, Nishiyama K, Suiko M, Tsubouchi H, Okayama A, Kataoka H. Rosemary Extract and Its Biological Active Substances, Carnosic Acid and Carnosol, Inhibit Growth of ATL Cells: Proteomic Analysis of ATL Cells. 13th International conference on human retrovirology: HTLV and related viruses. 2007. (May 21-25, Japan Kanagawa-ken, Hakone Prince Hotel).<\/li>\n
        24. Umeki K, Hisada M, Cranston B, Maloney ME, Hanchard MB, Okayama A. Analysis of Clonal Expansion of HTLV-1 Infected Cells in the Children in Jamaica. 13th International conference on human retrovirology: HTLV and related viruses. 2007. (May 21-25, Japan Kanagawa-ken, Hakone Prince Hotel).<\/li>\n
        25. Okayama A, Takajo I, Umeki K, Morishita K, Yamamoto I, Kubuki Y, Hatakeyama K, Kataoka H. Proliferation of HTLV-1-infected PBMC from Asymptomatic Carriers in NOD\/SCID\/3Null (NOG) Mice. 13th International conference on human retrovirology: HTLV and related viruses. 2007. (May 21-25, Japan Kanagawa-ken, Hakone Prince Hotel).<\/li>\n
        26. \u4e45\u51a8\u6728\u5eb8\u5b50, \u5150\u7389\u3000\u5efa, \u7af9\u30ce\u5185\u535a\u4e4b, \u5ca1\u5c71\u662d\u5f66. \u5f53\u9662\u306b\u304a\u3051\u308b\u65b0\u9bae\u51cd\u7d50\u306e\u4f7f\u7528\u72b6\u6cc1.\u3000\u7b2c55\u56de\u65e5\u672c\u8f38\u8840\u30fb\u7d30\u80de\u6cbb\u7642\u5b66\u4f1a\u7dcf\u4f1a. 2007. (5\u670831\u65e5-6\u67082\u65e5\uff081\u65e5\u767a\u8868\uff09,\u611b\u77e5\u770c\u540d\u53e4\u5c4b\u5e02, \u540d\u53e4\u5c4b\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
        27. \u7af9\u30ce\u5185\u535a\u4e4b, \u5150\u7389\u3000\u5efa, \u4e45\u51a8\u6728\u5eb8\u5b50, \u5ca1\u5c71\u662d\u5f66. \u5f53\u9662\u306b\u304a\u3051\u308b\u5fc3\u81d3\u8840\u7ba1\u5916\u79d1\u624b\u8853\u6642\u306e\u5c0f\u5150\u8853\u524d\u81ea\u5df1\u8840\u8caf\u8840\u306e\u73fe\u72b6\u306b\u3064\u3044\u3066. \u7b2c55\u56de\u65e5\u672c\u8f38\u8840\u30fb\u7d30\u80de\u6cbb\u7642\u5b66\u4f1a\u7dcf\u4f1a. 2007. (5\u670831\u65e5-6\u67082\u65e5(1\u65e5\u767a\u8868), \u611b\u77e5\u770c\u540d\u53e4\u5c4b\u5e02, \u540d\u53e4\u5c4b\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
        28. \u6e21\u908a\u88d5\u8cb4, \u7532\u6590\u6cf0\u6587, \u6885\u5317\u90a6\u5f66, \u6960\u5143\u898f\u751f, \u4e0a\u91ce\u53f2\u6717, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u5c71\u5143\u7f8e\u4fdd\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u9ed2\u6728\u660c\u5e78, \u4f50\u3005\u6728\u9686, \u9577\u53cb\u5b89\u5f18, \u677e\u5c71\u5e79\u592a\u90ce, \u5ca1\u5c71\u662d\u5f66. \u86cb\u767d\u6f0f\u51fa\u6027\u80c3\u8178\u75c7\u306b\u3088\u308b\u5927\u91cf\u80f8\u6c34\u3092\u5408\u4f75\u3057\u305f\u5168\u8eab\u6027\u30a8\u30ea\u30c6\u30de\u30c8\u30fc\u30c7\u30b9\uff08SLE\uff09. \u7b2c34\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a.\u30002007. (9\u67088\u65e5-9\u65e5, \u798f\u5ca1\u770c\u5317\u4e5d\u5dde\u5e02, \u5317\u4e5d\u5dde\u56fd\u969b\u4f1a\u8b70\u5834\u30fb\u30ea\u30fc\u30ac\u30ed\u30a4\u30e4\u30eb\u30db\u30c6\u30eb\u5c0f\u5009)<\/li>\n
        29. \u65e5\u9ad8\u5229\u5f66, \u5c71\u5143\u7f8e\u4fdd\u5b50, \u9ed2\u7530\u5b8f, \u7be0\u539f\u5178\u592b, \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u5927\u91cf\u51e6\u7406\u767d\u8840\u7403\u9664\u53bb\u7642\u6cd5\u306e\u77ed\u671f\u6210\u7e3e.\u3000\u7b2c34\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a.\u30002007. (9\u67088\u65e5-9\u65e5, \u798f\u5ca1\u770c\u5317\u4e5d\u5dde\u5e02\u3001\u5317\u4e5d\u5dde\u56fd\u969b\u4f1a\u8b70\u5834\u30fb\u30ea\u30fc\u30ac\u30ed\u30a4\u30e4\u30eb\u30db\u30c6\u30eb\u5c0f\u5009)<\/li>\n
        30. \u6a4b\u5834\u5f25\u751f, \u6885\u5317\u90a6\u5f66, \u4e0a\u91ce\u53f2\u6717, \u6960\u5143\u898f\u751f, \u7532\u6590\u6cf0\u6587, \u9ed2\u6728\u660c\u5e78, \u9577\u53cb\u5b89\u5f18,\u5357\u614e\u4e00, \u6771\u91ce\u54f2\u4e5f, \u5ca1\u5c71\u662d\u5f66. PR3-ANCA\u9670\u6027\u3001MPO-ANCA\u967d\u6027\u306eWegener\u8089\u82bd\u816b\u75c7\u306e1\u4f8b. \u7b2c34\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a.\u30002007. (9\u67088\u65e5-9\u65e5, \u798f\u5ca1\u770c\u5317\u4e5d\u5dde\u5e02, \u5317\u4e5d\u5dde\u56fd\u969b\u4f1a\u8b70\u5834\u30fb\u30ea\u30fc\u30ac\u30ed\u30a4\u30e4\u30eb\u30db\u30c6\u30eb\u5c0f\u5009)<\/li>\n
        31. Obase Y, Ohue Y, Kobashi Y, Ueno S, Miyashita N, Oka M. Clinical usefulness of exhaled breath temperature in asthma control. 17th Annual Congress of the European Respiratory Society Stockholm. 2007. (September 15, Sweden)<\/li>\n
        32. Obase Y, Ueno S, Ohue Y, Kobashi Y, Miyashita N, Oka M. The accuracy of asthma control test (act) inter linkage of asthma diary record. 17th Annual Congress of the European Respiratory Society Stockholm. 2007. (September 15, Sweden)<\/li>\n
        33. \u53e4\u5ddd\u90a6\u5b50, \u540d\u8d8a\u5eb7\u5b50, \u9b3c\u585a\u4e45\u5145, \u9234\u6728\u5343\u4ee3\u5b50, \u77e2\u91ce\u5149\u6d0b, \u4f0a\u9054\u6674\u5f66, \u4eca\u6751\u5353\u90ce,\u7530\u4e2d\u5f18\u4e4b, \u79cb\u5c71\u88d5, \u9b3c\u585a\u654f\u7537, \u5ca1\u5c71\u662d\u5f66, \u5317\u6751\u548c\u96c4. \u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u5de8\u5927\u306a\u5de6\u623f\u5fc3\u5185\u819c\u4e0b\u8840\u816b\u306e\u4e00\u4f8b. \u7b2c17\u56de\u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. 2007. (9\u670816\u65e5, \u798f\u5ca1\u770c\u5317\u4e5d\u5dde\u5e02)<\/li>\n
        34. Kobayashi I, Umeki K, Nomura H, Takajo, Yamamoto I, Umekita K, Okayama A. Analysis of HTLV-1 transmission and proviral loads in the asymptomatic carriers. The 66th Annual Meeting of the Japanese Cancer Association. 2007. (October 3-5, Kanagawa-ken Yokohama, PACIFICO YOKOHAMA)<\/li>\n
        35. Yamamoto I, Umeki K, Takajo I, Kobayashi I, Kubuki Y, Hatakeyama K, Kataoka H, Morishita K, Okayama A. HTLV-1 infection in the NOG mice. The 66th Annual Meeting of the Japanese Cancer Association. 2007. (October 3-5, Kanagawa-ken Yokohama, PACIFICO YOKOHAMA)<\/li>\n
        36. Morishita K, Tubouchi H, Hamasaki M, Hidaka T, Maeda K, Shimoda K, Marutsuka K, Hatakeyama K, Asada Y, Okayama A, Utsunomiya A, Ukai Y, Kurosawa G. Diagnostics development of adult T-cell leukemia by a novel surface marker, IGSF4\/TSLC-1. The 66th Annual Meeting of the Japanese Cancer Association. 2007. (October 3-5, Kanagawa-ken Yokohama, PACIFICO YOKOHAMA)<\/li>\n
        37. \u4e95\u4e0a\u6b66\u5fd7, \u7dd2\u65b9\u967d\u4e00, \u5965\u91ce\u3081\u3050\u307f, \u5c71\u5009\u3081\u3050\u307f, \u5ca1\u5c71\u662d\u5f66. \u5f53\u75c5\u9662\u306b\u304a\u3051\u308b\u91dd\u523a\u3057\u4e8b\u6545\u30fb\uff15\u5e74\u9593\u306e\u96c6\u8a08. \u7b2c42\u56de\u4e5d\u5dde\u533b\u5b66\u691c\u67fb\u5b66\u4f1a. 2007. (10\u67086\u65e5-7\u65e5, \u4f50\u8cc0\u770c)<\/li>\n
        38. \u5c71\u4e0b\u6e05, \u4e80\u7530\u62d3\u90ce, \u5e63\u5149\u592a\u90ce, \u4e0b\u7530\u6674\u5b50, \u9234\u6728\u6075\u5b50, \u4e45\u51a8\u6728\u5eb8\u5b50, \u5ca1\u5c71\u662d\u5f66,\u4e0b\u7530\u548c\u54c9. \u5316\u5b66\u7642\u6cd5\u4e2d\u306e\u8840\u6db2\u57f9\u990a\u967d\u6027\u8005\u306e\u89e3\u6790.\u3000\u7b2c69\u56de\u65e5\u672c\u8840\u6db2\u5b66\u4f1a\uff0f\u7b2c49\u56de\u65e5\u672c\u81e8\u5e8a\u8840\u6db2\u5b66\u4f1a\u7dcf\u4f1a.\u30002007. (10\u670811\u65e5-13\u65e5, \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02, \u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c)<\/li>\n
        39. Umekita K, Hidaka T, Takajyo I, Kai Y, Kuroki M, Nagatomo Y, Okayama A. Microparticles in Pheripheral Blood Decrease in Patients with Active Rheumatoid Arthritis by Leukocytapheresis. American College of Rheumatology ACR\/ARHP Annual Scientific Meeting. 2007. (November 6-11, Boston)<\/li>\n
        40. \u6960\u5143\u898f\u751f, \u6885\u5317\u90a6\u5f66, \u4e0a\u91ce\u53f2\u6717, \u9ed2\u6728\u660c\u5e78, \u7532\u6590\u6cf0\u6587, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18,\u5cf6\u7530\u96c5\u5df3, \u5ca1\u5c71\u662d\u5f66. \u813e\u645822\u5e74\u5f8c\u306b\u3001\u80ba\u708e\u7403\u83cc\u6027\u6557\u8840\u75c7\u30fb\u30d1\u30b9\u30c4\u30ec\u30e9\u80ba\u708e\u3092\u767a\u75c7\u3057\u305f1\u4f8b.\u3000\u7b2c77\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a.\u30002007. (11\u670815\u65e5-16\u65e5, \u4f50\u8cc0\u770c\u4f50\u8cc0\u5e02\u3001\u30db\u30c6\u30eb\u30cb\u30e5\u30fc\u30aa\u30fc\u30bf\u30cb\u4f50\u8cc0)<\/li>\n
        41. \u9ad8\u57ce\u4e00\u90ce, \u91ce\u6751\u5275, \u798f\u7530\u771f\u5f13, \u6b66\u7530\u5c55\u5e78, \u4f50\u4f2f\u88d5\u4e8c, \u5cf6\u7530\u96c5\u5df3, \u5ca1\u5c71\u662d\u5f66. \u8840\u6db2\u57f9\u990a\u306b\u304a\u3051\u308b\u30b7\u30e5\u30fc\u30c9\u30e2\u30ca\u30b9\u5c5e\u691c\u51fa\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c54\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7b2c47\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\u3000\u9023\u5408\u5927\u4f1a.\u30002007. (11\u670822\u65e5-25\u65e5,\u5927\u962a\u5e9c\u5927\u962a\u5e02\u3001\u5927\u962a\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
        42. \u91ce\u6751\u5275, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u7dd2\u65b9\u967d\u4e00, \u5c0f\u6797\u6a39, \u5ca1\u5c71\u662d\u5f66. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u672b\u68a2\u8840\u4e2d\u306e\u30de\u30a4\u30af\u30ed\u30d1\u30fc\u30c6\u30a3\u30af\u30eb\uff08MPs\uff09\u306e\u610f\u7fa9.\u3000\u7b2c54\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7b2c47\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\u3000\u9023\u5408\u5927\u4f1a. 2007. (11\u670822\u65e5-25\u65e5,\u5927\u962a\u5e9c\u5927\u962a\u5e02\u3001\u5927\u962a\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
        43. \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u6728\u660c\u5e78, \u6885\u5317\u90a6\u5f66, \u4e0a\u91ce\u53f2\u6717, \u9ad8\u57ce\u4e00\u90ce, \u7532\u6590\u6cf0\u6587, \u9577\u53cb\u5b89\u5f18,\u5ca1\u5c71\u662d\u5f66. \u81ea\u5df1\u8840\u30d5\u30a3\u30d6\u30ea\u30f3\u7cca\u306b\u3088\u308b\u7652\u7740\u8853\u304c\u6709\u52b9\u3067\u3042\u3063\u305f\u9593\u8cea\u6027\u80ba\u708e\u5408\u4f75\u6c17\u80f8\u306e1\u4f8b.\u3000\u7b2c59\u56de\u65e5\u672c\u7d50\u6838\u75c5\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a\u7dcf\u4f1a\u30fb\u7b2c59\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a\u7dcf\u4f1a.\u30002007. (11\u670822\u65e5-23\u65e5, \u5927\u5206\u770c\u5225\u5e9c\u5e02, B-CONPLAZA\u3000\u5927\u5206\u770c\u7acb\u5225\u5e9c\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        44. \u6885\u6728\u4e00\u7f8e, \u7dd2\u65b9\u967d\u4e00, \u5cf6\u7530\u96c5\u5df3, \u91ce\u6751\u5275, \u9ad9\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u5927\u5b66\u75c5\u9662\u691c\u67fb\u90e8\u306b\u304a\u3051\u308b\u6280\u5e2b\u30fb\u5b66\u751f\u6559\u80b2. \u7b2c46\u56de\u5bae\u5d0e\u770c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a. 2007. (11\u670825\u65e5, \u5bae\u5d0e\u770c)<\/li>\n
        45. \u9ad8\u677e\u5c1a\u6587, \u6d5c\u5d0e\u8aa0, \u65e5\u9ad8\u667a\u5fb3, \u5c71\u4e0b\u6e05, \u4e45\u5bcc\u6728\u5eb8\u5b50, \u9d5c\u98fc\u7531\u7bc4, \u5ca1\u5c71\u662d\u5f66, \u576a\u5185\u535a\u4ec1, \u9ed2\u6fa4\u4ec1, \u68ee\u4e0b\u548c\u5e83. \u6297IgSG4\/TSCL1\u6297\u4f53\u306b\u3088\u308b\u6210\u4ebaT\u7d30\u80de\u767d\u8840\u75c5(ATL)\u7d30\u80de\u306e\u691c\u51fa\u3068\u81e8\u5e8a\u5fdc\u7528.\u3000\u7b2c30\u56de\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a\u3000\u7b2c80\u56de\u65e5\u672c\u751f\u5316\u5b66\u5927\u4f1a\u3000\u5408\u540c\u5927\u4f1a.\u30002007. (12\u670814\u65e5, \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02, \u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c)<\/li>\n
        46. \u6960\u5143\u898f\u751f, \u6885\u5317\u90a6\u5f66, \u4e0a\u91ce\u53f2\u6717, \u9ad8\u57ce\u4e00\u90ce, \u7532\u6590\u6cf0\u6587, \u9ed2\u6728\u660c\u5e78, \u9577\u53cb\u5b89\u5f18,\u5ca1\u5c71\u662d\u5f66, \u4e80\u7530\u62d3\u90ce, \u5bae\u5185\u4fca\u4e00. \u6cbb\u7642\u306b\u3088\u308a\u623f\u5ba4\u30d6\u30ed\u30c3\u30af\u304c\u6539\u5584\u3057\u305f\u5168\u8eab\u6027\u30a8\u30ea\u30c6\u30de\u30c8\u30fc\u30c7\u30b9\u306e1\u4f8b. \u7b2c280\u56de\u3000\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u3000\u4e5d\u5dde\u5730\u65b9\u4f1a.\u30002008. (1\u670826\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
        47. \u91ce\u6751\u5275, \u6b66\u77e5\u9032\u58eb, \u5cf0\u677e\u4fca\u592b, \u5c71\u53e3\u5fe0\u654f, \u5ca1\u5c71\u662d\u5f66. \u7cd6\u7531\u6765\u751f\u6210\u7269\uff1a\u30b8\u30d2\u30c9\u30ed\u30d4\u30e9\u30b8\u30f3\u985e\u306e\u65b0\u898f\u8a98\u5c0e\u4f53\u306e\u7d30\u80de\u3078\u306e\u5f71\u97ff\u306b\u3064\u3044\u3066. \u7b2c18\u56de\u751f\u7269\u8a66\u6599\u5206\u6790\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.\u30002008. (2\u670810\u65e5-11\u65e5, \u5927\u962a\u5e9c\u5927\u962a\u5e02\u3001\u65b0\u6885\u7530\u7814\u4fee\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        48. \u4f50\u4f2f\u88d5\u4e8c, \u6b66\u7530\u5c55\u5e78, \u5cf6\u7530\u96c5\u5df3, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u8840\u6db2\u57f9\u990a\u3088\u308aStreptococcus suis\u3068Pasteurella multocida\u306e2\u83cc\u7a2e\u3092\u691c\u51fa\u3057\u305f\u6557\u8840\u75c7\u306e1\u75c7\u4f8b. \u7b2c18\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a\u3000\u7b2c52\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a.\u30002008. (2\u670816\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
        49. \u9234\u6728\u5343\u4ee3\u5b50, \u5c3e\u65b9\u7f8e\u5e78, \u732a\u5d0e\u307f\u3055\u304d, \u68ee\u5c71\u6676\u5b50, \u5ca1\u5c71\u662d\u5f66. \u96fb\u5b50\u30ab\u30eb\u30c6\u306b\u5bfe\u5fdc\u3057\u305f\u751f\u7406\u691c\u67fb\u30b7\u30b9\u30c6\u30e0. \u7b2c18\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a\u3000\u7b2c52\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a.\u30002008. (2\u670816\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
        50. \u7dd2\u65b9\u967d\u4e00, \u83c5\u6587\u6075, \u6885\u6728\u4e00\u7f8e, \u5cf6\u7530\u96c5\u5df3, \u5ca1\u5c71\u662d\u5f66. \u5730\u65b9\u306b\u304a\u3051\u308b\u5927\u5b66\u75c5\u9662\u691c\u67fb\u90e8\u306e\u5730\u57df\u533b\u7642\u3078\u306e\u5f79\u5272. \u7b2c18\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a\u3000\u7b2c52\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a.\u30002008. (2\u670816\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02,\u3000\u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
        51. \u5b88\u7530\u653f\u5ba3, \u7dd2\u65b9\u826f\u4e00, \u5927\u5ca9\u6839\u4e9c\u5e0c, \u6728\u7530\u4fe1\u7ae0, \u77f3\u9ed2\u9686\u4e00, \u5ca1\u5c71\u662d\u5f66. \u81ea\u7136\u707d\u5bb3\u306b\u5bfe\u3059\u308b\u691c\u67fb\u90e8\u306e\u4e8b\u524d\u5bfe\u5fdc\uff5e\u5c0f\u578b\u767a\u96fb\u6a5f\u306b\u3088\u308b\u6e2c\u5b9a\u7d50\u679c\u306e\u691c\u8a3c\uff5e. \u7b2c18\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a\u3000\u7b2c52\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a.\u30002008. (2\u670816\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02,\u3000\u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
        52. \u9ed2\u6728\u660c\u5e78, \u6885\u5317\u90a6\u5f66, \u6960\u5143\u898f\u751f, \u4e0a\u91ce\u53f2\u6717, \u9ad8\u57ce\u4e00\u90ce, \u7532\u6590\u6cf0\u6587, \u9577\u53cb\u5b89\u5f18,\u5ca1\u5c71\u662d\u5f66. C\u578b\u6162\u6027\u809d\u708e\u306e\u30a4\u30f3\u30bf\u30fc\u30d5\u30a7\u30ed\u30f3\u6cbb\u7642\u5f8c\u306b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u3092\u767a\u75c7\u3057\u305f\u4e00\u4f8b. \u7b2c35\u56de\u3000\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a.\u30002008. (3\u670815\u65e5-16\u65e5, \u6c96\u7e04\u770c\u5b9c\u91ce\u6e7e\u5e02,\u3000\u6c96\u7e04\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        53. 53) \u5c71\u8def\u5353\u5df3, \u9ed2\u6728\u660c\u5e78, \u6885\u5317\u90a6\u5f66, \u6960\u5143\u898f\u751f, \u4e0a\u91ce\u53f2\u6717, \u9ad8\u57ce\u4e00\u90ce, \u7532\u6590\u6cf0\u6587,\u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u591a\u767a\u6027\u7b4b\u708e\u306e\u8a3a\u65ad\u3067\u6cbb\u7642\u3092\u53d7\u3051\u3066\u3044\u305f\u80a2\u4f53\u578b\u7b4b\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u306e\u4e00\u4f8b. \u7b2c35\u56de\u3000\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. 2008. (3\u670815\u65e5-16\u65e5, \u6c96\u7e04\u770c\u5b9c\u91ce\u6e7e\u5e02,\u3000\u6c96\u7e04\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        54. \u4e0a\u91ce\u53f2\u6717, \u6960\u5143\u898f\u751f, \u6885\u5317\u90a6\u5f66, \u9ed2\u6728\u660c\u5e78, \u7532\u6590\u6cf0\u6587, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18,\u5ca1\u5c71\u662d\u5f66, \u79cb\u5c71\u88d5, \u4e38\u585a\u6d69\u52a9. \u8457\u660e\u306a\u7b4b\u529b\u4f4e\u4e0b\u3092\u304d\u305f\u3057\u305f\u30b5\u30eb\u30b3\u30a4\u30c9\u7b4b\u708e\u306e1\u4f8b. \u7b2c35\u56de\u3000\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. 2008. (3\u670815\u65e5-16\u65e5, \u6c96\u7e04\u770c\u5b9c\u91ce\u6e7e\u5e02,\u3000\u6c96\u7e04\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        55. \u65e5\u9ad8\u5229\u5f66, \u5c71\u5143\u7f8e\u4fdd\u5b50, \u524d\u7530\u5553\u4e00, \u9ed2\u7530\u3000\u5b8f, \u7be0\u539f\u5178\u592b. C\u578b\u809d\u708e\u5408\u4f75\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306b\u5bfe\u3057\u3066\u30a8\u30bf\u30cd\u30eb\u30bb\u30d7\u30c8\u304a\u3088\u3073\u30a4\u30f3\u30bf\u30fc\u30d5\u30a7\u30ed\u30f3\u7642\u6cd5\u3092\u4f75\u7528\u3057\u305f\uff12\u4f8b. \u7b2c35\u56de\u3000\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a.\u30002008. (3\u670815\u65e5-16\u65e5, 16\u65e5\u767a\u8868, \u6c96\u7e04\u770c\u5b9c\u91ce\u6e7e\u5e02,\u3000\u6c96\u7e04\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n<\/ol>\n
          \"btn-pagetop1\"<\/a><\/div>\n

          C. \u305d\u306e\u4ed6<\/h3>\n
          \n

          –<\/p>\n<\/div>\n

          \"btn-pagetop1\"<\/a><\/div>\n

          D. \u7279\u8a31\u51fa\u9858<\/h3>\n

          –<\/p>\n

          \"btn-pagetop1\"<\/a><\/div>\n

          <\/p>\n

          \u5185\u8a33\u6570<\/h2>\n

          A.\u8ad6\u6587\uff1a\u8457\u66f8(2)\u3001\u539f\u8457\uff082\uff09\u3001\u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09\uff083\uff09\u3001\u7dcf\u8aac\uff080\uff09\u3000B.\u767a\u8868\uff1a\u5b66\u4f1a\u767a\u8868\uff0855\uff09\u3001\u305d\u306e\u4ed6\uff080\uff09 C.\u305d\u306e\u4ed6\uff080\uff09\u3000D.\u7279\u8a31\u51fa\u9858\uff080\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"

          A. \u8ad6\u6587 \u3010\u8457\u66f8\u3011 Matsuda Z, Iga M, Miyauchi K, Komano J, Morishita K, Okayama A, Tsubouchi H. Section 7 In vitro tra […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[9],"tags":[],"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/226"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/comments?post=226"}],"version-history":[{"count":0,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/226\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/media?parent=226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/categories?post=226"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/tags?post=226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}